Index of /data/fantom5/20190329/sym_link/data-1/basic/human.cell_line.CAGEScan

[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.bam2017-01-26 17:56 403M 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.bam2017-01-26 17:56 401M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.bam2017-01-26 17:55 389M 
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 323M 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.bam2017-01-26 17:56 318M 
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 305M 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.bam2017-01-26 17:56 303M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 297M 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.bam2017-01-26 17:56 295M 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 291M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.bam2017-01-26 17:56 288M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 288M 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 280M 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 272M 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 264M 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 260M 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.bam2017-01-26 17:56 260M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.bam2017-01-26 17:56 256M 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 256M 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 249M 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 243M 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 230M 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.bam2017-01-26 17:56 225M 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 222M 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.bam2017-01-26 17:55 220M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.bam2017-01-26 17:56 215M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.bam2017-01-26 17:54 211M 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.bam2017-01-26 17:56 209M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.bam2017-01-26 17:56 203M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.bam2017-01-26 17:56 195M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.bam2017-01-26 17:55 191M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.bam2017-01-26 17:56 190M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 190M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.bam2017-01-26 17:54 181M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 181M 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 177M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.bam2017-01-26 17:55 176M 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 173M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 171M 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 168M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 166M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 164M 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 164M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 163M 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 157M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 157M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 156M 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 154M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 154M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 154M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.bam2017-01-26 17:55 152M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 151M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 151M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.bam2017-01-26 17:56 150M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 150M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 146M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 144M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 143M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.3prime.fq.gz2017-01-26 17:54 143M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 142M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 141M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.5prime.fq.gz2017-01-26 17:54 141M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 121M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 121M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.3prime.fq.gz2017-01-26 17:55 118M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.5prime.fq.gz2017-01-26 17:55 117M 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 81M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 81M 
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 79M 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 64M 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 63M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 63M 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 55M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 54M 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 52M 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 47M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 41M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 41M 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 41M 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 40M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 39M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 39M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 38M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 34M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 30M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 27M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.pairs.bed.gz2017-01-26 17:54 27M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.pairs.bed.gz2017-01-26 17:55 26M 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.bam.bai2017-01-26 17:55 5.3M 
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.bam.bai2017-01-26 17:55 5.2M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.bam.bai2017-01-26 17:55 5.0M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.bam.bai2017-01-26 17:55 4.7M 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.bam.bai2017-01-26 17:55 4.6M 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.bam.bai2017-01-26 17:55 4.5M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.bam.bai2017-01-26 17:55 4.5M 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.bam.bai2017-01-26 17:55 4.4M 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.bam.bai2017-01-26 17:54 4.4M 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.bam.bai2017-01-26 17:55 4.3M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.bam.bai2017-01-26 17:56 4.2M 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.bam.bai2017-01-26 17:55 4.2M 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.bam.bai2017-01-26 17:56 4.2M 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.bam.bai2017-01-26 17:55 4.1M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.bam.bai2017-01-26 17:55 4.0M 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.bam.bai2017-01-26 17:55 3.9M 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.bam.bai2017-01-26 17:55 3.9M 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.bam.bai2017-01-26 17:55 3.9M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.bam.bai2017-01-26 17:55 3.7M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.bam.bai2017-01-26 17:55 3.7M 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.bam.bai2017-01-26 17:55 3.7M 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.bam.bai2017-01-26 17:55 3.7M 
[ ]acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 886K 
[ ]malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 863K 
[ ]schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 862K 
[ ]glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 806K 
[ ]signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 698K 
[ ]maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 697K 
[ ]renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 687K 
[ ]epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 676K 
[ ]chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 536K 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 533K 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.clusters.bed.gz2017-01-26 17:55 507K 
[ ]osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 506K 
[ ]myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.clusters.bed.gz2017-01-26 17:55 478K 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 436K 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 435K 
[ ]splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 431K 
[ ]cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 427K 
[ ]neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 389K 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 379K 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 371K 
[ ]extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.clusters.bed.gz2017-01-26 17:54 323K 
[ ]synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.clusters.bed.gz2017-01-26 17:55 315K 
[TXT]00_human.cell_line.CAGEScan.hg19.assay_sdrf.txt2017-01-26 14:13 17K